{"transactions":[{"id":1003299,"issuer":{"id":1179,"kind":"organization","name":"COHERENT CORP.","symbol":"COHR"},"owners":[{"id":52008,"kind":"organization","name":"Bain Capital Investors LLC","position":1,"cik":"0001040508","reported_name":"BAIN CAPITAL INVESTORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73377,"kind":"organization","name":"Bain Capital Fund XII, LP","position":2,"cik":"0001706270","reported_name":"Bain Capital Fund XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73378,"kind":"organization","name":"Bain Capital Partners XII, LLC","position":3,"cik":"0001830424","reported_name":"Bain Capital Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73379,"kind":"organization","name":"BCPE Watson (DE) Aggregator GP, LLC","position":4,"cik":"0001911154","reported_name":"BCPE Watson (DE) Aggregator GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73380,"kind":"organization","name":"BCPE Watson (DE) Aggregator, LP","position":5,"cik":"0001911143","reported_name":"BCPE Watson (DE) Aggregator, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73381,"kind":"organization","name":"BCPE Watson (DE) BML GP, LLC","position":6,"cik":"0001910886","reported_name":"BCPE Watson (DE) BML GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73382,"kind":"organization","name":"BCPE Watson (DE) BML, LP","position":7,"cik":"0001910890","reported_name":"BCPE Watson (DE) BML, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Convertible Preferred Stock","published_at":"2025-11-13T01:59:53.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":false,"shares":54023,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On November 7, 2025, the Reporting Persons converted 54,023 shares of Series B-1 Convertible Preferred Stock (\"Series B-1 Preferred Stock\" and, together with the Series B-2 Convertible Preferred Stock, the \"Series B Preferred Stock\") into 7,754,253 shares of Common Stock.  Series B-1 Preferred Stock was issued on March 31, 2021 pursuant to the Statement with Respect to Shares setting forth the terms of the Series B Convertible Preferred Stock filed with the Pennsylvania Department of State Corporations Bureau and effective March 30, 2021 (the \"Statement with Respect to Shares\"). Subject to adjustments set forth in the Statement with Respect to Shares, from the issuance date of such share, dividends accrue daily on the applicable stated value of each share of the Series B Preferred Stock at 5% per annum with an initial stated value of $10,000 per share."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Until the fourth anniversary of the applicable issuance date, all dividend payments are compounded and added to the applicable stated value on a quarterly basis (a \"PIK Dividend\"). Following the fourth anniversary of the applicable issuance date, dividends will be payable in the form of, at the Issuer's sole discretion, (i) cash, (ii) a PIK Dividend or (iii) any combination of both. Commencing on July 1, 2022, each share of Series B Preferred Stock became convertible, at the option of the holder, into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price. The conversion price of the Series B Preferred Stock is initially $85.00 per share, subject to adjustments set forth in the Statement with Respect to Shares."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In addition, at any time after the third anniversary of the applicable issuance date, if the closing sale price of the Issuer's common stock exceeds 150% of the then-applicable conversion price for 20 trading days in any 30 consecutive trading day period, the Issuer may elect to convert all of the shares of the applicable series of Series B Preferred Stock into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price in accordance with the Statement with Respect to Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 7, 2025, the Reporting Persons converted 54,023 shares of Series B-1 Convertible Preferred Stock (\"Series B-1 Preferred Stock\" and, together with the Series B-2 Convertible Preferred Stock, the \"Series B Preferred Stock\") into 7,754,253 shares of Common Stock.  Series B-1 Preferred Stock was issued on March 31, 2021 pursuant to the Statement with Respect to Shares setting forth the terms of the Series B Convertible Preferred Stock filed with the Pennsylvania Department of State Corporations Bureau and effective March 30, 2021 (the \"Statement with Respect to Shares\"). Subject to adjustments set forth in the Statement with Respect to Shares, from the issuance date of such share, dividends accrue daily on the applicable stated value of each share of the Series B Preferred Stock at 5% per annum with an initial stated value of $10,000 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Until the fourth anniversary of the applicable issuance date, all dividend payments are compounded and added to the applicable stated value on a quarterly basis (a \"PIK Dividend\"). Following the fourth anniversary of the applicable issuance date, dividends will be payable in the form of, at the Issuer's sole discretion, (i) cash, (ii) a PIK Dividend or (iii) any combination of both. Commencing on July 1, 2022, each share of Series B Preferred Stock became convertible, at the option of the holder, into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price. The conversion price of the Series B Preferred Stock is initially $85.00 per share, subject to adjustments set forth in the Statement with Respect to Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In addition, at any time after the third anniversary of the applicable issuance date, if the closing sale price of the Issuer's common stock exceeds 150% of the then-applicable conversion price for 20 trading days in any 30 consecutive trading day period, the Issuer may elect to convert all of the shares of the applicable series of Series B Preferred Stock into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price in accordance with the Statement with Respect to Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 7, 2025, the Reporting Persons converted 54,023 shares of Series B-1 Convertible Preferred Stock (\"Series B-1 Preferred Stock\" and, together with the Series B-2 Convertible Preferred Stock, the \"Series B Preferred Stock\") into 7,754,253 shares of Common Stock.  Series B-1 Preferred Stock was issued on March 31, 2021 pursuant to the Statement with Respect to Shares setting forth the terms of the Series B Convertible Preferred Stock filed with the Pennsylvania Department of State Corporations Bureau and effective March 30, 2021 (the \"Statement with Respect to Shares\"). Subject to adjustments set forth in the Statement with Respect to Shares, from the issuance date of such share, dividends accrue daily on the applicable stated value of each share of the Series B Preferred Stock at 5% per annum with an initial stated value of $10,000 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Until the fourth anniversary of the applicable issuance date, all dividend payments are compounded and added to the applicable stated value on a quarterly basis (a \"PIK Dividend\"). Following the fourth anniversary of the applicable issuance date, dividends will be payable in the form of, at the Issuer's sole discretion, (i) cash, (ii) a PIK Dividend or (iii) any combination of both. Commencing on July 1, 2022, each share of Series B Preferred Stock became convertible, at the option of the holder, into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price. The conversion price of the Series B Preferred Stock is initially $85.00 per share, subject to adjustments set forth in the Statement with Respect to Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In addition, at any time after the third anniversary of the applicable issuance date, if the closing sale price of the Issuer's common stock exceeds 150% of the then-applicable conversion price for 20 trading days in any 30 consecutive trading day period, the Issuer may elect to convert all of the shares of the applicable series of Series B Preferred Stock into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price in accordance with the Statement with Respect to Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On November 7, 2025, the Reporting Persons converted 54,023 shares of Series B-1 Convertible Preferred Stock (\"Series B-1 Preferred Stock\" and, together with the Series B-2 Convertible Preferred Stock, the \"Series B Preferred Stock\") into 7,754,253 shares of Common Stock.  Series B-1 Preferred Stock was issued on March 31, 2021 pursuant to the Statement with Respect to Shares setting forth the terms of the Series B Convertible Preferred Stock filed with the Pennsylvania Department of State Corporations Bureau and effective March 30, 2021 (the \"Statement with Respect to Shares\"). Subject to adjustments set forth in the Statement with Respect to Shares, from the issuance date of such share, dividends accrue daily on the applicable stated value of each share of the Series B Preferred Stock at 5% per annum with an initial stated value of $10,000 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Until the fourth anniversary of the applicable issuance date, all dividend payments are compounded and added to the applicable stated value on a quarterly basis (a \"PIK Dividend\"). Following the fourth anniversary of the applicable issuance date, dividends will be payable in the form of, at the Issuer's sole discretion, (i) cash, (ii) a PIK Dividend or (iii) any combination of both. Commencing on July 1, 2022, each share of Series B Preferred Stock became convertible, at the option of the holder, into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price. The conversion price of the Series B Preferred Stock is initially $85.00 per share, subject to adjustments set forth in the Statement with Respect to Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In addition, at any time after the third anniversary of the applicable issuance date, if the closing sale price of the Issuer's common stock exceeds 150% of the then-applicable conversion price for 20 trading days in any 30 consecutive trading day period, the Issuer may elect to convert all of the shares of the applicable series of Series B Preferred Stock into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price in accordance with the Statement with Respect to Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Directly held by BCPE Watson (DE) BML, LP (\"BML\"). BCPE Watson (DE) BML GP, LLC (\"BML GP\") is the general partner of BML. As a result, BML GP may be deemed to share voting and dispositive power with respect to the securities held by BML. BML GP disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Bain Capital Investors, LLC (\"BCI\") is the manager of Bain Capital Partners XII, LLC (\"Partners XII\"), which is the general partner of Bain Capital Fund XII, L.P. (\"Fund XII\"). Fund XII is the sole member of BCPE Watson (DE) Aggregator GP, LLC (\"Aggregator GP\"), which is the general partner of BCPE Watson (DE) Aggregator, LP (\"Aggregator\"). Aggregator is the sole member of BML GP. As a result, each of BCI, Partners XII, Fund XII, Aggregator GP and Aggregator may be deemed to share voting and dispositive power with respect to the securities held by  BML. Each of BCI, Partners XII, Fund XII, Aggregator GP and Aggregator disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."}],"balance_after":20977,"derivative":{"underlying":"Common Stock","underlying_shares":7754252},"source":{"system":"sec-edgar","filing":"0001193125-25-278400","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1040508/000119312525278400/ownership.xml","form_type":"4"}},{"id":1003298,"issuer":{"id":1179,"kind":"organization","name":"COHERENT CORP.","symbol":"COHR"},"owners":[{"id":52008,"kind":"organization","name":"Bain Capital Investors LLC","position":1,"cik":"0001040508","reported_name":"BAIN CAPITAL INVESTORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73377,"kind":"organization","name":"Bain Capital Fund XII, LP","position":2,"cik":"0001706270","reported_name":"Bain Capital Fund XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73378,"kind":"organization","name":"Bain Capital Partners XII, LLC","position":3,"cik":"0001830424","reported_name":"Bain Capital Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73379,"kind":"organization","name":"BCPE Watson (DE) Aggregator GP, LLC","position":4,"cik":"0001911154","reported_name":"BCPE Watson (DE) Aggregator GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73380,"kind":"organization","name":"BCPE Watson (DE) Aggregator, LP","position":5,"cik":"0001911143","reported_name":"BCPE Watson (DE) Aggregator, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73381,"kind":"organization","name":"BCPE Watson (DE) BML GP, LLC","position":6,"cik":"0001910886","reported_name":"BCPE Watson (DE) BML GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73382,"kind":"organization","name":"BCPE Watson (DE) BML, LP","position":7,"cik":"0001910890","reported_name":"BCPE Watson (DE) BML, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T01:59:53.000Z","date":"2025-11-10","kind":"other","planned":false,"acquired":false,"shares":254252,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"On November 10, 2025, BML, distributed 254,252 shares of Common Stock to one or more members or partners of BML in connection with certain charitable gifts to be made by such members or partners or their direct or indirect owners."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On November 10, 2025, BML, distributed 254,252 shares of Common Stock to one or more members or partners of BML in connection with certain charitable gifts to be made by such members or partners or their direct or indirect owners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Directly held by BCPE Watson (DE) BML, LP (\"BML\"). BCPE Watson (DE) BML GP, LLC (\"BML GP\") is the general partner of BML. As a result, BML GP may be deemed to share voting and dispositive power with respect to the securities held by BML. BML GP disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Bain Capital Investors, LLC (\"BCI\") is the manager of Bain Capital Partners XII, LLC (\"Partners XII\"), which is the general partner of Bain Capital Fund XII, L.P. (\"Fund XII\"). Fund XII is the sole member of BCPE Watson (DE) Aggregator GP, LLC (\"Aggregator GP\"), which is the general partner of BCPE Watson (DE) Aggregator, LP (\"Aggregator\"). Aggregator is the sole member of BML GP. As a result, each of BCI, Partners XII, Fund XII, Aggregator GP and Aggregator may be deemed to share voting and dispositive power with respect to the securities held by  BML. Each of BCI, Partners XII, Fund XII, Aggregator GP and Aggregator disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-278400","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1040508/000119312525278400/ownership.xml","form_type":"4"}},{"id":1003297,"issuer":{"id":1179,"kind":"organization","name":"COHERENT CORP.","symbol":"COHR"},"owners":[{"id":52008,"kind":"organization","name":"Bain Capital Investors LLC","position":1,"cik":"0001040508","reported_name":"BAIN CAPITAL INVESTORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73377,"kind":"organization","name":"Bain Capital Fund XII, LP","position":2,"cik":"0001706270","reported_name":"Bain Capital Fund XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73378,"kind":"organization","name":"Bain Capital Partners XII, LLC","position":3,"cik":"0001830424","reported_name":"Bain Capital Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73379,"kind":"organization","name":"BCPE Watson (DE) Aggregator GP, LLC","position":4,"cik":"0001911154","reported_name":"BCPE Watson (DE) Aggregator GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73380,"kind":"organization","name":"BCPE Watson (DE) Aggregator, LP","position":5,"cik":"0001911143","reported_name":"BCPE Watson (DE) Aggregator, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73381,"kind":"organization","name":"BCPE Watson (DE) BML GP, LLC","position":6,"cik":"0001910886","reported_name":"BCPE Watson (DE) BML GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73382,"kind":"organization","name":"BCPE Watson (DE) BML, LP","position":7,"cik":"0001910890","reported_name":"BCPE Watson (DE) BML, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T01:59:53.000Z","date":"2025-11-07","kind":"sale","planned":false,"acquired":false,"shares":7500000,"price":143.37,"value":1075275000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Directly held by BCPE Watson (DE) BML, LP (\"BML\"). BCPE Watson (DE) BML GP, LLC (\"BML GP\") is the general partner of BML. As a result, BML GP may be deemed to share voting and dispositive power with respect to the securities held by BML. BML GP disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Bain Capital Investors, LLC (\"BCI\") is the manager of Bain Capital Partners XII, LLC (\"Partners XII\"), which is the general partner of Bain Capital Fund XII, L.P. (\"Fund XII\"). Fund XII is the sole member of BCPE Watson (DE) Aggregator GP, LLC (\"Aggregator GP\"), which is the general partner of BCPE Watson (DE) Aggregator, LP (\"Aggregator\"). Aggregator is the sole member of BML GP. As a result, each of BCI, Partners XII, Fund XII, Aggregator GP and Aggregator may be deemed to share voting and dispositive power with respect to the securities held by  BML. Each of BCI, Partners XII, Fund XII, Aggregator GP and Aggregator disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."}],"balance_after":254252,"source":{"system":"sec-edgar","filing":"0001193125-25-278400","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1040508/000119312525278400/ownership.xml","form_type":"4"}},{"id":1003296,"issuer":{"id":1179,"kind":"organization","name":"COHERENT CORP.","symbol":"COHR"},"owners":[{"id":52008,"kind":"organization","name":"Bain Capital Investors LLC","position":1,"cik":"0001040508","reported_name":"BAIN CAPITAL INVESTORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73377,"kind":"organization","name":"Bain Capital Fund XII, LP","position":2,"cik":"0001706270","reported_name":"Bain Capital Fund XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73378,"kind":"organization","name":"Bain Capital Partners XII, LLC","position":3,"cik":"0001830424","reported_name":"Bain Capital Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73379,"kind":"organization","name":"BCPE Watson (DE) Aggregator GP, LLC","position":4,"cik":"0001911154","reported_name":"BCPE Watson (DE) Aggregator GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73380,"kind":"organization","name":"BCPE Watson (DE) Aggregator, LP","position":5,"cik":"0001911143","reported_name":"BCPE Watson (DE) Aggregator, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73381,"kind":"organization","name":"BCPE Watson (DE) BML GP, LLC","position":6,"cik":"0001910886","reported_name":"BCPE Watson (DE) BML GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73382,"kind":"organization","name":"BCPE Watson (DE) BML, LP","position":7,"cik":"0001910890","reported_name":"BCPE Watson (DE) BML, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T01:59:53.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":true,"shares":7754252,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 7, 2025, the Reporting Persons converted 54,023 shares of Series B-1 Convertible Preferred Stock (\"Series B-1 Preferred Stock\" and, together with the Series B-2 Convertible Preferred Stock, the \"Series B Preferred Stock\") into 7,754,253 shares of Common Stock.  Series B-1 Preferred Stock was issued on March 31, 2021 pursuant to the Statement with Respect to Shares setting forth the terms of the Series B Convertible Preferred Stock filed with the Pennsylvania Department of State Corporations Bureau and effective March 30, 2021 (the \"Statement with Respect to Shares\"). Subject to adjustments set forth in the Statement with Respect to Shares, from the issuance date of such share, dividends accrue daily on the applicable stated value of each share of the Series B Preferred Stock at 5% per annum with an initial stated value of $10,000 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Until the fourth anniversary of the applicable issuance date, all dividend payments are compounded and added to the applicable stated value on a quarterly basis (a \"PIK Dividend\"). Following the fourth anniversary of the applicable issuance date, dividends will be payable in the form of, at the Issuer's sole discretion, (i) cash, (ii) a PIK Dividend or (iii) any combination of both. Commencing on July 1, 2022, each share of Series B Preferred Stock became convertible, at the option of the holder, into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price. The conversion price of the Series B Preferred Stock is initially $85.00 per share, subject to adjustments set forth in the Statement with Respect to Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"In addition, at any time after the third anniversary of the applicable issuance date, if the closing sale price of the Issuer's common stock exceeds 150% of the then-applicable conversion price for 20 trading days in any 30 consecutive trading day period, the Issuer may elect to convert all of the shares of the applicable series of Series B Preferred Stock into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price in accordance with the Statement with Respect to Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 7, 2025, the Reporting Persons converted 54,023 shares of Series B-1 Convertible Preferred Stock (\"Series B-1 Preferred Stock\" and, together with the Series B-2 Convertible Preferred Stock, the \"Series B Preferred Stock\") into 7,754,253 shares of Common Stock.  Series B-1 Preferred Stock was issued on March 31, 2021 pursuant to the Statement with Respect to Shares setting forth the terms of the Series B Convertible Preferred Stock filed with the Pennsylvania Department of State Corporations Bureau and effective March 30, 2021 (the \"Statement with Respect to Shares\"). Subject to adjustments set forth in the Statement with Respect to Shares, from the issuance date of such share, dividends accrue daily on the applicable stated value of each share of the Series B Preferred Stock at 5% per annum with an initial stated value of $10,000 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Until the fourth anniversary of the applicable issuance date, all dividend payments are compounded and added to the applicable stated value on a quarterly basis (a \"PIK Dividend\"). Following the fourth anniversary of the applicable issuance date, dividends will be payable in the form of, at the Issuer's sole discretion, (i) cash, (ii) a PIK Dividend or (iii) any combination of both. Commencing on July 1, 2022, each share of Series B Preferred Stock became convertible, at the option of the holder, into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price. The conversion price of the Series B Preferred Stock is initially $85.00 per share, subject to adjustments set forth in the Statement with Respect to Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In addition, at any time after the third anniversary of the applicable issuance date, if the closing sale price of the Issuer's common stock exceeds 150% of the then-applicable conversion price for 20 trading days in any 30 consecutive trading day period, the Issuer may elect to convert all of the shares of the applicable series of Series B Preferred Stock into a number of shares of the Issuer's common stock equal to the then-applicable stated value divided by the then-applicable conversion price in accordance with the Statement with Respect to Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Directly held by BCPE Watson (DE) BML, LP (\"BML\"). BCPE Watson (DE) BML GP, LLC (\"BML GP\") is the general partner of BML. As a result, BML GP may be deemed to share voting and dispositive power with respect to the securities held by BML. BML GP disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Bain Capital Investors, LLC (\"BCI\") is the manager of Bain Capital Partners XII, LLC (\"Partners XII\"), which is the general partner of Bain Capital Fund XII, L.P. (\"Fund XII\"). Fund XII is the sole member of BCPE Watson (DE) Aggregator GP, LLC (\"Aggregator GP\"), which is the general partner of BCPE Watson (DE) Aggregator, LP (\"Aggregator\"). Aggregator is the sole member of BML GP. As a result, each of BCI, Partners XII, Fund XII, Aggregator GP and Aggregator may be deemed to share voting and dispositive power with respect to the securities held by  BML. Each of BCI, Partners XII, Fund XII, Aggregator GP and Aggregator disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."}],"balance_after":7754252,"source":{"system":"sec-edgar","filing":"0001193125-25-278400","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1040508/000119312525278400/ownership.xml","form_type":"4"}},{"id":1442332,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":52008,"kind":"organization","name":"Bain Capital Investors LLC","position":1,"cik":"0001040508","reported_name":"BAIN CAPITAL INVESTORS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88528,"kind":"person","name":"BC Perception Holdings, LP","position":2,"cik":"0001829166","reported_name":"BC Perception Holdings, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88529,"kind":"person","name":"BCPE Perception GP, LLC","position":3,"cik":"0001829130","reported_name":"BCPE Perception GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73377,"kind":"organization","name":"Bain Capital Fund XII, LP","position":4,"cik":"0001706270","reported_name":"Bain Capital Fund XII, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73378,"kind":"organization","name":"Bain Capital Partners XII, LLC","position":5,"cik":"0001830424","reported_name":"Bain Capital Partners XII, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T20:52:52.000Z","date":"2024-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65679781,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated December 6, 2023, by and among AbbVie Inc. (\"Parent\"), Symphony Harlan LLC, Symphony Harlan Merger Sub Inc. (\"Merger Sub\") and Cerevel Therapeutics Holdings, Inc. (\"Issuer\"), on August 1, 2024 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive $45.00 in cash, without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated December 6, 2023, by and among AbbVie Inc. (\"Parent\"), Symphony Harlan LLC, Symphony Harlan Merger Sub Inc. (\"Merger Sub\") and Cerevel Therapeutics Holdings, Inc. (\"Issuer\"), on August 1, 2024 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive $45.00 in cash, without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares of common stock held directly by BC Perception Holdings, LP (\"BC Perception\"). Bain Capital Fund XII, L.P. (\"Fund XII\") is the sole member of BCPE Perception GP, LLC (\"Perception GP\"), which is the general partner of BC Perception. Bain Capital Investors, LLC (\"BCI\") is the manager of Bain Capital Partners XII, LLC (\"Partners XII\" and, together with BCI, BC Perception, Fund XII and Perception GP, the \"Bain Capital Entities\"), which is the general partner of Fund XII. As a result, each of the Bain Capital Entities may be deemed to share voting and dispositive power with respect to the shares of common stock held by BC Perception. Each of the Bain Capital Entities disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-090909","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1040508/000095017024090909/ownership.xml","form_type":"4"}},{"id":1758715,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":52008,"kind":"organization","name":"Bain Capital Investors LLC","position":1,"cik":"0001040508","reported_name":"BAIN CAPITAL INVESTORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88528,"kind":"person","name":"BC Perception Holdings, LP","position":2,"cik":"0001829166","reported_name":"BC Perception Holdings, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88529,"kind":"person","name":"BCPE Perception GP, LLC","position":3,"cik":"0001829130","reported_name":"BCPE Perception GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73377,"kind":"organization","name":"Bain Capital Fund XII, LP","position":4,"cik":"0001706270","reported_name":"Bain Capital Fund XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73378,"kind":"organization","name":"Bain Capital Partners XII, LLC","position":5,"cik":"0001830424","reported_name":"Bain Capital Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-18T20:30:09.000Z","date":"2023-10-16","kind":"purchase","planned":false,"acquired":true,"shares":5480052,"price":22.81,"value":124999986.12,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On October 16, 2023, BC Perception purchased 5,480,052 shares of the Issuer's common stock at a price of $22.81 per share in an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares of the Issuer's common stock held directly by BC Perception Holdings, LP (\"BC Perception\"). Bain Capital Fund XII, L.P. (\"Fund XII\") is the sole member of BCPE Perception GP, LLC (\"Perception GP\"), which is the general partner of BC Perception. Bain Capital Investors, LLC (\"BCI\") is the manager of Bain Capital Partners XII, LLC (\"Partners XII\" and, together with BCI, BC Perception, Fund XII and Perception GP, the \"Bain Capital Entities\"), which is the general partner of Fund XII. As a result, each of the Bain Capital Entities may be deemed to share voting and dispositive power with respect to the shares of the Issuer's common stock held by BC Perception. Each of the Bain Capital Entities disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."}],"balance_after":65679781,"source":{"system":"sec-edgar","filing":"0000899243-23-019969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1040508/000089924323019969/doc4.xml","form_type":"4"}},{"id":1859827,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":52008,"kind":"organization","name":"Bain Capital Investors LLC","position":1,"cik":"0001040508","reported_name":"BAIN CAPITAL INVESTORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88528,"kind":"person","name":"BC Perception Holdings, LP","position":2,"cik":"0001829166","reported_name":"BC Perception Holdings, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88529,"kind":"person","name":"BCPE Perception GP, LLC","position":3,"cik":"0001829130","reported_name":"BCPE Perception GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73377,"kind":"organization","name":"Bain Capital Fund XII, LP","position":4,"cik":"0001706270","reported_name":"Bain Capital Fund XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73378,"kind":"organization","name":"Bain Capital Partners XII, LLC","position":5,"cik":"0001830424","reported_name":"Bain Capital Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T22:05:26.000Z","date":"2023-06-07","kind":"other","planned":false,"acquired":false,"shares":432627,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 7, 2023, BC Perception distributed an aggregate of 432,627 shares of the Issuer's common stock (the \"Distributed Shares\") to certain of its limited partners in a pro-rata in-kind distribution to such limited partners in connection with a redemption of their partnership interests. The Bain Capital Entities did not have a pecuniary interest in any of the Distributed Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bain Capital Fund XII, L.P. (\"Fund XII\") is the sole member of BCPE Perception GP, LLC (\"Perception GP\"), which is the general partner of BC Perception Holdings, LP (\"BC Perception\"). Bain Capital Investors, LLC (\"BCI\") is the manager of Bain Capital Partners XII, LLC (\"Partners XII\" and, together with BCI, BC Perception, Fund XII and Perception GP, the \"Bain Capital Entities\"), which is the general partner of Fund XII. As a result, each of the Bain Capital Entities may be deemed to share voting and dispositive power with respect to the shares of the Issuer's common stock held by BC Perception. Each of the Bain Capital Entities disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."}],"balance_after":60199729,"source":{"system":"sec-edgar","filing":"0000899243-23-015402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1040508/000089924323015402/doc4.xml","form_type":"4"}},{"id":2985787,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":52008,"kind":"organization","name":"Bain Capital Investors LLC","position":1,"cik":"0001040508","reported_name":"BAIN CAPITAL INVESTORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88528,"kind":"person","name":"BC Perception Holdings, LP","position":2,"cik":"0001829166","reported_name":"BC Perception Holdings, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88529,"kind":"person","name":"BCPE Perception GP, LLC","position":3,"cik":"0001829130","reported_name":"BCPE Perception GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73377,"kind":"organization","name":"Bain Capital Fund XII, LP","position":4,"cik":"0001706270","reported_name":"Bain Capital Fund XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73378,"kind":"organization","name":"Bain Capital Partners XII, LLC","position":5,"cik":"0001830424","reported_name":"Bain Capital Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T22:54:59.000Z","date":"2020-11-09","kind":"purchase","acquired":true,"shares":332293,"price":10.3,"value":3422617.9,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bain Capital Fund XII, L.P. (\"Fund XII\") is the sole member of BCPE Perception GP, LLC (\"Perception GP\"), which is the general partner of BC Perception Holdings, LP (\"BC Perception\"). Bain Capital Investors, LLC (\"BCI\") is the manager of Bain Capital Partners XII, LLC (\"Partners XII\" and, together with BCI, BC Perception, Fund XII and Perception GP, the \"Bain Capital Entities\"), which is the general partner of Fund XII. As a result, each of the Bain Capital Entities may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by BC Perception. Each of the Bain Capital Entities disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."}],"balance_after":60632356,"source":{"system":"sec-edgar","filing":"0000899243-20-030861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1040508/000089924320030861/doc4.xml","form_type":"4"}},{"id":2998492,"issuer":{"id":15182,"kind":"organization","name":"Cerevel Therapeutics Holdings, Inc.","symbol":"CERE"},"owners":[{"id":52008,"kind":"organization","name":"Bain Capital Investors LLC","position":1,"cik":"0001040508","reported_name":"BAIN CAPITAL INVESTORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88528,"kind":"person","name":"BC Perception Holdings, LP","position":2,"cik":"0001829166","reported_name":"BC Perception Holdings, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88529,"kind":"person","name":"BCPE Perception GP, LLC","position":3,"cik":"0001829130","reported_name":"BCPE Perception GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73377,"kind":"organization","name":"Bain Capital Fund XII, LP","position":4,"cik":"0001706270","reported_name":"Bain Capital Fund XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73378,"kind":"organization","name":"Bain Capital Partners XII, LLC","position":5,"cik":"0001830424","reported_name":"Bain Capital Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T00:00:09.000Z","date":"2020-10-27","kind":"purchase","acquired":true,"shares":10000000,"price":10,"value":100000000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 27, 2020, BC Perception Holdings, LP (\"BC Perception\") purchased 10,000,000 shares of the Issuer's Common Stock from the Issuer at a price of $10.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bain Capital Fund XII, L.P. (\"Fund XII\") is the sole member of BCPE Perception GP, LLC (\"Perception GP\"), which is the general partner of BC Perception. Bain Capital Investors, LLC (\"BCI\") is the manager of Bain Capital Partners XII, LLC (\"Partners XII\" and, together with BCI, BC Perception, Fund XII and Perception GP, the \"Bain Capital Entities\"), which is the general partner of Fund XII. As a result, each of the Bain Capital Entities may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by BC Perception. Each of the Bain Capital Entities disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein."}],"balance_after":60300063,"source":{"system":"sec-edgar","filing":"0000899243-20-029740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1040508/000089924320029740/doc4.xml","form_type":"4"}}]}